Brief: Medtronic Q2 Adjusted EPS USD 1.36 Vs. IBES Estimate USD 1.31
18/11/2025 11:45
Nov 18 (Reuters) - Medtronic Q2 revenue USD 9,000 million vs. IBES estimate USD 8,865 million. outlook FY organic growth 5.5% outlook FY adjusted EPS USD 5.62-5.66
Recent news on Medtronic
See all newsStreet View: Medtronic moves from 'show me' story to 'trust the setup' story
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway
Medtronic climbs after Q4 results beat estimates